Correlation Between AstraZeneca PLC and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AstraZeneca PLC and Eli Lilly and, you can compare the effects of market volatilities on AstraZeneca PLC and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Eli Lilly.

Diversification Opportunities for AstraZeneca PLC and Eli Lilly

0.02

Correlation Coefficient

AstraZeneca PLC  Eli Lilly

Significant diversification

The 3 months correlation between AstraZeneca and Eli is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Eli Lilly go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Eli Lilly

Assuming the 90 days horizon AstraZeneca PLC is expected to generate 4.56 times less return on investment than Eli Lilly. In addition to that, AstraZeneca PLC is 1.22 times more volatile than Eli Lilly and. It trades about 0.02 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.12 per unit of volatility. If you would invest  31,211  in Eli Lilly and on January 19, 2024 and sell it today you would earn a total of  43,772  from holding Eli Lilly and or generate 140.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	99.78%
Values	Daily Returns

AstraZeneca PLC  vs.  Eli Lilly and

AstraZeneca PLC

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain fundamental indicators, AstraZeneca PLC may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Eli Lilly

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AstraZeneca PLC and Eli Lilly

The main advantage of trading using opposite AstraZeneca PLC and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind AstraZeneca PLC and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.